EMPIRICO Trademark

Trademark Overview


On Monday, December 31, 2018, a trademark application was filed for EMPIRICO with the United States Patent and Trademark Office. The USPTO has given the EMPIRICO trademark a serial number of 88246067. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Saturday, November 29, 2025. This trademark is owned by Empirico Inc.. The EMPIRICO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research in the fields of pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research in the field of treatment of infectious, deficiency, hereditary, and physiological diseases; medical research in connection with various diseases and disorders, including eosinophilic diseases, asthma, CRS, and allergic rhinitis, autoimmune diseases, including psoriasis, vitiligo, and lichen planus, ocular diseases, including intraocular pressure and glaucoma, and atopic dermatitis
empirico

General Information


Serial Number88246067
Word MarkEMPIRICO
Filing DateMonday, December 31, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateSaturday, November 29, 2025
Registration Number6109523
Registration DateTuesday, July 21, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research in the fields of pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research in the field of treatment of infectious, deficiency, hereditary, and physiological diseases; medical research in connection with various diseases and disorders, including eosinophilic diseases, asthma, CRS, and allergic rhinitis, autoimmune diseases, including psoriasis, vitiligo, and lichen planus, ocular diseases, including intraocular pressure and glaucoma, and atopic dermatitis
Translation of Words in MarkThe English translation of "EMPIRICO" in the mark is "EMPIRICAL".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 23, 2019
Primary Code042
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameEmpirico Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Party NameEmpirico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events


Event DateEvent Description
Thursday, January 3, 2019NEW APPLICATION ENTERED
Wednesday, January 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 20, 2019ASSIGNED TO EXAMINER
Wednesday, March 20, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 3, 2020TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 3, 2020TEAS AMENDMENT OF USE RECEIVED
Monday, April 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 3, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, April 28, 2020DIVISIONAL PROCESSING COMPLETE
Friday, April 3, 2020USE AMENDMENT FILED
Tuesday, April 28, 2020AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, May 27, 2020USE AMENDMENT ACCEPTED
Wednesday, May 27, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, May 28, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, June 2, 2020ASSIGNED TO LIE
Wednesday, June 10, 2020ASSIGNED TO LIE
Wednesday, June 17, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 21, 2020REGISTERED-SUPPLEMENTAL REGISTER
Monday, July 21, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 29, 2025TEAS SECTION 8 RECEIVED
Saturday, November 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 29, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, November 29, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED